Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Eterna Therapeutics ( (ERNA) ) is now available.
On June 12, 2025, Ernexa Therapeutics Inc. implemented a reverse stock split of its common stock at a ratio of 1-for-15 by filing a certificate of amendment with the Secretary of State of Delaware. This corporate action is likely aimed at consolidating shares to potentially enhance the company’s stock price and improve its market perception.
More about Eterna Therapeutics
Average Trading Volume: 360,017
Technical Sentiment Signal: Strong Sell
Current Market Cap: $9.67M
For a thorough assessment of ERNA stock, go to TipRanks’ Stock Analysis page.